Wachovia upgrades Gilead Sciences (Nasdaq: GILD) from Market Perform to Outperform with a $47-$50 valuation range, citing valuation.

This article: 93 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE